About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government ...

JPMorgan Chase & Co. (JPM) came out with quarterly earnings of $4.40 per share, beating the Zacks Consensus Estimate of $4.19 per share. This compares to earnings of $4.37 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 5.01%. A quarter ago, it was expected that this company would post earnings of $4.18 per share when it actually produced earnings of $4.63, delivering a surprise of 10.77%.Over the last four quarters, the compa ...

2Q24 Financial Results July 12, 2024 2Q24 Financial highlights Std. RWA4 $1.7TCET1 capital ratios3 ROTCE1 28% Std. 15.3% | Adv. 15.5%Cash and marketable securities5 $1.5T ROTCE ex. significant items2 20% Total Loss-Absorbing Capacity3 $534BAverage loans $1.3T ⚫ 2Q24 net income of $18.1B and EPS of $6.12 – Excluding significant items2, 2Q24 net income of $13.1B, EPS of $4.40 and ROTCE of 20% Income statement ⚫ Managed revenue of $51.0B6 ⚫ Expense of $23.7B and managed overhead ratio of 47%6 ⚫ Loans: average ...

Exhibit 99.2 EARNINGS RELEASE FINANCIAL SUPPLEMENT SECOND QUARTER 2024 JPMORGAN CHASE & CO. TABLE OF CONTENTS | --- | --- | |-------------------------------------------------|---------| | | Page(s) | | Consolidated Results | | | Consolidated Financial Highlights | 2–3 | | Consolidated Statements of Income | 4 | | Consolidated Balance Sheets | 5 | | Condensed Average Balance Sheets and Annualized | | | Yields | 6 | | Reconciliation from Reported to Managed Basis | 7 | | Segment Results - Managed Basis | 8 | ...

The race at JPMorgan to replace CEO Jamie Dimon is on full throttle – even if the mega-bank is doing a great job keeping a lid on the contretemps from leaking to the press. The legendary financier recently shocked the banking world when he said he would step down sooner than his original time frame of five years – maybe two or three years when he’s 70 years of age or so.I say “shocked” because Dimon is still at the top of his game, keeping JPMorgan largely scandal-free and holding the distinction as maybe t ...

The second-quarter 2024 earnings for the Finance sector start tomorrow, with three big banks – JPMorgan (JPM) , Citigroup (C) , and Wells Fargo (WFC) – slated to announce quarterly numbers. Another big bank, Bank of America (BAC) , will come up with results on Jul 16.Heading into the earnings season, investors seem to be tremendously bullish about these big banks’ quarterly performance. All four stocks touched 52-week/all-time highs in recent days. America’s biggest bank – JPMorgan – scaled an all-time high ...

In its upcoming report, JPMorgan Chase & Co. (JPM) is predicted by Wall Street analysts to post quarterly earnings of $4.19 per share, reflecting a decline of 4.1% compared to the same period last year. Revenues are forecasted to be $45.67 billion, representing a year-over-year increase of 10.6%.Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted upward by 0.8% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections ...

Key Announcement - Joseph Siletto joins J P Morgan Private Capital as Co Managing Partner alongside Anya Schiess and Gaurav Gupta reporting to Stephen Squinto [1] - The expanded team will focus on investing in Series B through pre IPO stage healthcare companies specifically in biotechnology medical devices health technology and services and diagnostics and tools subsectors [1] Joseph Siletto's Background - Joseph Siletto has over 25 years of experience in private healthcare investments most recently as Managing Director at Vivo Capital [2] - He co founded Scion Medical Technologies which was sold to NYSE listed Varian Medical and is now part of Siemens [4] - Prior to Vivo Capital he was an investment banker at Cowen & Company and Banc of America Securities focusing on healthcare M&A and capital raising [4] Strategic Focus of J P Morgan Life Sciences Private Capital - The platform aims to finance opportunities that enhance disease treatment and patient outcomes while reducing costs through innovative treatment methods cutting edge technology AI driven treatments improved diagnostic tools and cost effective healthcare solutions [3] - The team believes advancements in biotechnology and AI will transform the healthcare industry and position them as a preferred partner for innovative companies [3] About J P Morgan Private Capital - J P Morgan Private Capital provides customized financing solutions for private companies with a focus on venture and growth investing across consumer technology and life sciences sectors [5] - It is part of J P Morgan Global Alternatives which manages $214 billion in assets as of March 31 2024 and covers a wide range of alternative investment strategies [6] About J P Morgan Asset Management - J P Morgan Asset Management manages $3 2 trillion in assets as of March 31 2024 serving institutions retail investors and high net worth individuals globally [7] - It offers investment management in equities fixed income real estate hedge funds private equity and liquidity [7] About JPMorgan Chase & Co - JPMorgan Chase & Co is a leading financial services firm with $4 1 trillion in assets and $337 billion in stockholders equity as of March 31 2024 [8] - The firm operates globally in investment banking financial services for consumers and small businesses commercial banking financial transaction processing and asset management [8]

JP Morgan headquarters at Canary Wharf financial district at the heart of Canary Wharf financial ... [+] district on 7th May 2024 in London, United Kingdom. (photo by Mike Kemp/In Pictures via Getty Images)In Pictures via Getty ImagesJPMorgan (NYSE: JPM) stock has gained 21% YTD, as compared to the 17% rise in the S&P500 index. Notably, JPMorgan’s peer Citigroup (NYSE: C) is up 22% YTD. JPM is scheduled to report its fiscal Q2 2024 results on Friday, July 12, 2024. We expect JPMorgan to post mixed results w ...

There's a reason the country's single biggest banking name is holding up against a headwind.In theory, this isn't a great time to own bank stocks. Although high interest rates make lending money a more profitable business, the persistent inflation these high rates are meant to curb is bad for the economy, and it crimps demand for most basic banking services.In reality, however, most banks (and their stocks) are doing well. Shares of JPMorgan Chase (JPM 1.20%) logged a gain of more than 21% during the first ...